Used in pharmaceutical research as a key intermediate in the synthesis of immunomodulatory and anticancer agents. It serves as a structural analog in the development of compounds targeting protein degradation pathways, particularly cereblon (CRBN)-based E3 ubiquitin ligase modulators. This makes it valuable in designing drugs for hematological cancers such as multiple myeloma and myelodysplastic syndromes. Also explored for its potential in inflammatory and autoimmune disease therapy due to its ability to influence cytokine production and T-cell activation.